Guillain-Barre syndrome after vaccination in United States a report from the CDC/FDA Vaccine Adverse Event Reporting System.
Using the data from Vaccine Adverse Event Reporting System, we present 54 reports of Guillain-Barre Syndrome (GBS) after vaccination that occurred in United States in 2004. In 38 of the patients, GBS occurred within 6 weeks. The highest number (n=31) of GBS was observed in patients receiving influenza vaccine followed by hepatitis vaccine (n=9), 1 patient died and 10 patients were disabled following the event. We conclude that vaccines other than influenza vaccine can be associated with GBS.
Souayah
Nizar
N
Epidemiological and Outcomes Research Division, Zeenat Qureshi Stroke Research Center, Department of Medicine, University of Medicine and Dentistry of New Jersey, 90 Bergen Street, DOC 8100, Newark, NJ 07103, United States. souayani@umdny.edu
Nasar
Abu
A
Suri
M Fareed K
MF
Qureshi
Adnan I
AI
D000328:Adult; D016907:Adverse Drug Reaction Reporting Systems; D020275:Guillain-Barre Syndrome / Q000453:epidemiology*; D006801:Humans; D015994:Incidence; D007252:Influenza Vaccines / Q000009:adverse effects; D014481:United States; D014611:Vaccination / Q000009:adverse effects*
D007252:Influenza Vaccines